(Q44939463)

7 December 2017

Liposomal doxorubicin (Doxil): an effective new treatment for Kaposi's sarcoma in AIDS. (English)

1 reference

7 December 2017

0 references

0 references

1 reference

James ND

1

1 reference

7 December 2017

Coker RJ

2

1 reference

7 December 2017

Tomlinson D

3

1 reference

7 December 2017

Harris JR

4

1 reference

7 December 2017

Gompels M

5

1 reference

7 December 2017

Pinching AJ

6

1 reference

7 December 2017

Stewart JS

7

1 reference

7 December 2017

1 January 1994

1 reference

7 December 2017

1 reference

7 December 2017

6

1 reference

7 December 2017

5

1 reference

7 December 2017

294-296

1 reference

Kaposi's sarcoma in a cohort of homosexual and bisexual men. Epidemiology and analysis for cofactors

7 December 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0936-6555%2805%2980269-9

7 January 2021

Kaposi's sarcoma among persons with AIDS: a sexually transmitted infection?

1 reference

https://api.crossref.org/works/10.1016%2FS0936-6555%2805%2980269-9

7 January 2021

Systemic treatment of AIDS-related Kaposi's sarcoma: Results of a randomized trial

1 reference

https://api.crossref.org/works/10.1016%2FS0936-6555%2805%2980269-9

7 January 2021

Treatment of epidemic Kaposi's sarcoma with etoposide or a combination of doxorubicin, bleomycin, and vinblastine.

1 reference

https://api.crossref.org/works/10.1016%2FS0936-6555%2805%2980269-9

7 January 2021

Kaposi's sarcoma and AIDS

1 reference

https://api.crossref.org/works/10.1016%2FS0936-6555%2805%2980269-9

7 January 2021

Kaposi's sarcoma in the acquired immune deficiency syndrome: a proposal for uniform evaluation, response, and staging criteria. AIDS Clinical Trials Group Oncology Committee

1 reference

https://api.crossref.org/works/10.1016%2FS0936-6555%2805%2980269-9

7 January 2021

10.1016/S0936-6555(05)80269-9

Identifiers

DOI

1 reference

7 December 2017

1 reference